Published in Clin J Am Soc Nephrol on March 01, 2008
A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood (2012) 1.10
Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Validity of cardiovascular risk prediction models in kidney transplant recipients. ScientificWorldJournal (2014) 0.77
The reverse remodeling of the aorta in patients after renal transplantation - the value of aortic stiffness index: prospective echocardiographic study. BMC Nephrol (2017) 0.75
Chapter 5: Blood pressure management in kidney transplant recipients (CKD T). Kidney Int Suppl (2011) (2012) 0.75
Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients. Int J Angiol (2016) 0.75
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 9.53
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis (2007) 3.96
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation (2003) 3.79
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension (2005) 2.69
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med (2001) 2.27
Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol (2002) 2.19
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation (2001) 2.13
Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis (2003) 2.04
Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol (1998) 2.02
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int (2002) 1.76
Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant (2004) 1.61
Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol (2000) 1.60
Hypertension after kidney transplantation. Am J Kidney Dis (2004) 1.59
Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol (2006) 1.57
Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol (1999) 1.50
The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int (2005) 1.46
Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study. Nephron Clin Pract (2003) 1.46
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int (2001) 1.45
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int (1998) 1.37
Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol (2006) 1.29
Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis (2003) 1.17
Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant (2005) 1.17
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol (2002) 1.16
Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol (2003) 1.16
Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol (2002) 1.13
Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation (1995) 1.11
Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation (2001) 1.10
Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant (2004) 1.09
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. Am Heart J (2006) 1.09
Cigarette smoking in renal transplant recipients. J Am Soc Nephrol (2000) 1.07
Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation (2005) 1.05
Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney Int (1999) 1.03
Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant (2007) 1.02
Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc (2001) 1.01
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int (1998) 0.99
Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest (1993) 0.98
Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens (1998) 0.98
A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97
Coronary artery calcification in renal transplant recipients. Am J Transplant (2005) 0.97
The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int (2007) 0.96
Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc (2003) 0.95
Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation (2004) 0.94
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension. Nephrol Dial Transplant (2002) 0.92
Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients. J Am Soc Nephrol (2007) 0.91
Markers of inflammation before and after renal transplantation. Transplantation (2005) 0.90
Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther (1996) 0.90
Effects of successful renal transplantation on left ventricular mass. Transplant Proc (2005) 0.90
The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design. Nephrol Dial Transplant (2007) 0.89
Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int (1995) 0.88
A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. Am J Kidney Dis (2003) 0.87
A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation (2001) 0.87
Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med (1985) 0.86
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients. Am J Transplant (2005) 0.85
Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. Kidney Int Suppl (1998) 0.83
C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant (2004) 0.83
Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass. Nephrol Dial Transplant (2007) 0.82
Hypertension after renal transplantation. J Am Soc Nephrol (1994) 0.81
Impaired arterial compliance and aerobic endurance in kidney transplant recipients. Transplantation (2006) 0.81
Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg (2005) 0.81
Dynamics of the circadian blood pressure profiles after renal transplantation. Transplantation (2005) 0.80
Cardiovascular disease posttransplant. Semin Nephrol (2007) 0.80
Hyperhomocyst(e)inemia as a risk factor after renal transplantation. Ann Transplant (2001) 0.79
Hypertension after kidney transplantation: impact, pathogenesis and therapy. Am J Med Sci (2003) 0.78
Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction. Transplantation (2003) 0.77
Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis (2001) 0.76
Cyclosporine and posttransplant hypertension. J Am Soc Nephrol (1992) 0.76
IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis (2006) 0.76